Sexual problems are a common complaint among people with MS. Studies estimate that 40 to 85 percent of women and 50 to 90 percent of men report some type of…
Read More
The connection between multiple sclerosis and vitamin D levels is an area of study that has long been of interest to researchers and people who are living with MS. A…
Over the last thirty years, we’ve refined our understanding of MS. With each research study, another dot is added to our picture of the disease. It’s certainly not a straight…
At the Rocky Mountain MS Center we periodically survey people in the MS community to find out what they want from us. A frequent, frustrated response is, “A cure for…
Earlier this fall, PCORI (the Patient Centered Outcomes Research Institute) released a request for funding applications for comparative effectiveness studies of Multiple sclerosis (MS) disease modifying therapies (DMTs). This includes…
Untitled Document Support the MS Center The Rocky Mountain MS Center is a 501(c)(3) Charitable Organization, Federal ID number 84-0795455. We have been rated a Gold Participant by GuideStar Exchange, an independent…
We have an update for you regarding Ocrelizumab – the investigational disease modifying therapy that we have told you about over the past several months. Last week, the FDA…
https://youtu.be/79-neCtENZ8 Join the RMMSC’s Dr. Enrique Alvarez as he discusses the latest developments in MS research, including those presented at the 2016 ECTRIMS conference in Europe. If you were not…
Get Ready for Ski Season with Adaptive Ski Passes! The snow has started falling in the mountains and ski season is beginning here in the Rockies! If you are a…
You're Reading:
About the Author
This content was compiled by Rocky Mountain MS Center staff members.